IO Biotech, Inc. (IOBTQ) Enterprise Value (2020 - 2025)

IO Biotech (IOBTQ) has 6 years of Enterprise Value data on file, last reported at -$30.7 million in Q3 2025.

• Quarterly Enterprise Value rose 61.76% year-over-year to -$30.7 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$30.7 million (up 61.76% YoY) and the FY2024 annual result came in at -$60.0 million, up 58.08% from the prior year.
• Enterprise Value retreated to -$30.7 million in Q3 2025, from -$28.1 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$28.1 million in Q2 2025 to a low of -$211.5 million in Q4 2021.
• A 5-year average of -$106.8 million and a median of -$110.1 million in 2023 frame the typical range for Enterprise Value.
• Annual changes were most pronounced in 2021 — Enterprise Value tumbled 6112.36% — and 2025, when it jumped 72.08%.
• Tracing IOBTQ's Enterprise Value over 5 years: stood at -$211.5 million in 2021, then surged by 32.59% to -$142.6 million in 2022, then dropped by 0.42% to -$143.2 million in 2023, then soared by 58.08% to -$60.0 million in 2024, then jumped by 48.92% to -$30.7 million in 2025.
• The last three Enterprise Value figures came in at -$30.7 million (Q3 2025), -$28.1 million (Q2 2025), and -$37.1 million (Q1 2025), per Business Quant data.